-
St. Jude Soars 30% After Abbott Announces $25 Billion Acquisition
Thursday, April 28, 2016 - 7:38am | 398Read More...Shares of St. Jude Medical, Inc. (NYSE: STJ) soared higher by nearly 30 percent Thursday morning after Abbott Laboratories (NYSE: ABT) announced it has entered into an agreement to acquire the medical device manufacturer. As part of the agreement, Abbott will acquire St. Jude for a total...
-
How Much Does It Cost To Develop A New Drug?
Wednesday, August 14, 2013 - 9:32am | 590Read More...Don’t expect to get a direct answer from any of the big pharma firms, but in the world of big data, the answer, or something pretty close to answer, was found by doing some simple math. Last year, Forbes columnist Matthew Herper went back to the basics and simply divided each company’s spending...
-
Johnson & Johnson Provides Justification To Stay On The Sidelines
Wednesday, July 21, 2010 - 7:31am | 112Read More...According to Goldman Sachs, Johnson & Johnson (NYSE: JNJ) was highlighted with risk as it headed into it's 2Q due to $0.11 below consensus rating and potential management guidance reduction for 2010 due to cost-restructuring challenges. Goldman has maintained Johnson & Johnson at "neutral...
